PubRank

Maria Victoria Mateos

Author PubWeight™ 11.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. J Clin Oncol 2008 2.09
2 Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics. J Clin Oncol 2007 1.29
3 The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin Cancer Res 2011 1.28
4 Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials. Haematologica 2013 1.26
5 The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients. Blood 2009 1.10
6 Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Haematologica 2009 1.08
7 Medium-term results of percutaneous vertebroplasty in multiple myeloma. Eur J Haematol 2006 0.92
8 Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. Haematologica 2010 0.90
9 Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group. Eur J Haematol 2007 0.79
10 Multiple myeloma: treatment evolution. Hematology 2012 0.77
11 A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia. Curr Med Res Opin 2007 0.77
12 Acute loss of vision as the initial symptom of multiple myeloma. Clin Lymphoma Myeloma Leuk 2012 0.75
13 Frontline treatment in elderly patients with multiple myeloma. Semin Hematol 2009 0.75